<DOC>
	<DOCNO>NCT00648986</DOCNO>
	<brief_summary>The purpose study determine whether topical tazarotene ( Tazorac ) , receptor-selective synthetic retinoid normalize epidermal differentiation , ameliorate sign symptom brittle nail .</brief_summary>
	<brief_title>Efficacy Safety Study Tazarotene ( Tazorac ) Treatment Brittle Nails</brief_title>
	<detailed_description>`` Brittle nail , '' refer nails chip , peel , split excessively , occur 30 % woman 15 % men , high prevalence among elderly . Treatment brittle nails involve restoration maintenance normal degree nail plate hydration minimize exposure dehydrate chemical use moisturizers , alpha-hydroxy acid . Retinoids vitamin A analogs play role skin cell differentiation proliferation . Tazarotene topical receptor-selective synthetic retinoid normalize epidermal differentiation reduces influx inflammatory cell skin . In single-center , open-label trial , subject apply tazarotene nail twice daily 24 week . Signs symptom rat investigator subject treatment 12 week discontinuation .</detailed_description>
	<mesh_term>Tazarotene</mesh_term>
	<mesh_term>Nicotinic Acids</mesh_term>
	<criteria>Patient provide IRBapproved write informed consent prior conduct studyrelated procedure Men female patient 18 75 year age Have diagnosis brittle nail Have two target fingernail identify baseline Have evidence least two follow sign symptom brittle nails select nail plate severe sign ( one ) target nail : trachyonychia ( surface roughness ) lamellar onychoschizia ( horizontal layering ) longitudinal crack split distal edge Female patient childbearing potential ( surgically sterile least 2 year postmenopausal ) negative pregnancy test baseline/day 1 lactate Sexually active female subject surgically sterile 2 year post menopausal must agree use contraception/birth control measure study ( e.g. , oral contraceptive , diaphragm spermicide , condom spermicide , intrauterine device , Norplant System , DepoProvera , tubal ligation ) Patients agree selfadminister topical study medication , agree complete study procedure Patient judge good health medical history physical examination Must able adhere study visit schedule protocol requirement Have history surgery affect fingernail Are pregnant , nursing , plan pregnancy prior study enrollment Have disturbance shape affect fingernail ( e.g. , due malformation underlie bone ) would interfere investigator 's ability evaluate photograph Have onycholysis ( lift nail plate nailbed ) affect fingernail Have fungal infection affect fingernail Have history psoriasis lichen planus involve nail , active contact dermatitis involve affect fingernail Have use topical cosmetic medicate product affect nail within 2 week baseline visit Have receive oral antifungal treatment within 3 month baseline visit Have know suspected history genetic condition affect nail ( e.g. , Darier 's disease , nailpatella syndrome , tuberculosis sclerosis ) Immune compromise due HIV infection , organ transplantation , treatment malignancy Chronic liver , heart , kidney , ( untreated ) thyroid disease Have use investigational drug within previous 1 month 5 halflives investigational agent , whichever long , 3 month biologic unknown halflife Are know substance abuse ( drug alcohol ) problem within previous 3 year Unlikely comply study protocol prescribe treatment unsuitable reason opinion investigator Have current sign symptom severe , progressive , uncontrolled renal , hepatic , hematologic , gastrointestinal , endocrine , pulmonary , cardiac , neurologic , cerebral disease ; Currently know malignancy history malignancy nonmelanoma skin cancer Are know infected human immunodeficiency virus ( HIV ) , hepatitis B hepatitis C Have sign bacterial , fungal viral skin lesion may interfere measurement target lesion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>76 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>brittle nail</keyword>
	<keyword>Tazarotene</keyword>
	<keyword>Tazorac</keyword>
</DOC>